Joshua B. Cohen
Director & Co-Chief Executive Officer
SEC EDGAR ↗Director & Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc., filing insider transactions on 2026-09-10.
Total Purchases
—
0 transactions
Total Sales
$981K
2 transactions
Companies Traded
1
2 total filings
Active Since
2026-09-10
Last: 2026-09-10
Other Reporting Insiders at Amylyx Pharmaceuticals, Inc.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-09-10 | AMLX | Sale | 29.5K | $32.16 | $950K | 3.61M | SEC ↗ |
| 2026-09-10 | AMLX | Sale | 919 | $33.15 | $30K | 3.61M | SEC ↗ |
Director & Co-Chief Executive Officer
Joshua B. Cohen (Amylyx Pharmaceuticals, Inc.) Insider Trades | Tormere